These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32128334)

  • 1. Short-term Increase in Risk of Overweight and Concomitant Systolic Blood Pressure Elevation in Treatment-Naïve Persons Starting INSTI-Based Antiretroviral Therapy.
    Galdamez R; García JA; Fernández M; Robledano C; Agulló V; García-Abellán J; Telenti G; Padilla S; Gutiérrez F; Masiá M
    Open Forum Infect Dis; 2019 Dec; 6(12):ofz491. PubMed ID: 32128334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy.
    Bourgi K; Rebeiro PF; Turner M; Castilho JL; Hulgan T; Raffanti SP; Koethe JR; Sterling TR
    Clin Infect Dis; 2020 Mar; 70(7):1267-1274. PubMed ID: 31100116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States.
    Rebeiro PF; Emond B; Rossi C; Bookhart BK; Shah A; Caron-Lapointe G; Lafeuille MH; Donga P
    J Int AIDS Soc; 2023 Jun; 26(6):e26123. PubMed ID: 37306118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Integrase Strand Transfer Inhibitor-Based Antiretroviral Therapy with Blood Pressure and Sustained Hypertension in People with HIV.
    Siddiqui M; Burkholder GA; Judd E; Wang Z; Colantonio LD; Ghazi L; Shimbo D; Willig AL; Overton ET; Oparil S; Levitan EB; Heath SL; Muntner P
    Am J Hypertens; 2024 Jun; ():. PubMed ID: 38890772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors.
    Chen YW; Anderson D; Pericone CD; Donga P
    J Health Econ Outcomes Res; 2022; 9(1):1-10. PubMed ID: 35083364
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration.
    Rein SM; Lodi S; Logan RW; Touloumi G; Antoniadou A; Wittkop L; Bonnet F; van Sighem A; van der Valk M; Reiss P; Klein MB; Young J; Jarrin I; d'Arminio Monforte A; Tavelli A; Meyer L; Tran L; Gill MJ; Lang R; Surial B; Haas AD; Justice AC; Rentsch CT; Phillips A; Sabin CA; Miro JM; Trickey A; Ingle SM; Sterne JAC; Hernán MA;
    Lancet HIV; 2023 Nov; 10(11):e723-e732. PubMed ID: 37923486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral Therapy Anchor-based Trends in Body Mass Index Following Treatment Initiation Among Military Personnel with HIV.
    Kline MDA; Daniels C; Xu X; Sunil T; Ganesan A; Agan BK; Colombo RE; Kronmann KC; Blaylock JM; Okulicz JF; Markelz AE
    Mil Med; 2021 Feb; 186(3-4):279-285. PubMed ID: 33128552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor.
    Verburgh ML; Wit FWNM; Boyd A; Verboeket SO; Reiss P; van der Valk M
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac291. PubMed ID: 35873291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study.
    Martínez-Sanz J; Blanco JR; Muriel A; Pérez-Elías MJ; Rubio-Martín R; Berenguer J; Peraire J; Bernal E; Martínez OJ; Serrano-Villar S; Moreno S;
    J Int AIDS Soc; 2021 May; 24(5):e25732. PubMed ID: 34036745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Assessment of Weight Change in People with HIV-1 After Initiating Integrase Strand Transfer Inhibitors or Protease Inhibitors.
    Chen YW; Hardy H; Pericone CD; Chow W
    J Health Econ Outcomes Res; 2020; 7(2):102-110. PubMed ID: 32766375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.
    Surial B; Chammartin F; Damas J; Calmy A; Haerry D; Stöckle M; Schmid P; Bernasconi E; Fux CA; Tarr PE; Günthard HF; Wandeler G; Rauch A;
    Clin Infect Dis; 2023 Sep; 77(5):729-737. PubMed ID: 37157869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium.
    Byonanebye DM; Polizzotto MN; Neesgaard B; Sarcletti M; Matulionyte R; Braun DL; Castagna A; de Wit S; Wit F; Fontas E; Vehreschild JJ; Vesterbacka J; Greenberg L; Hatleberg C; Garges H; Gallant J; Volny Anne A; Öllinger A; Mozer-Lisewska I; Surial B; Spagnuolo V; Necsoi C; van der Valk M; Mocroft A; Law M; Ryom L; Petoumenos K;
    HIV Med; 2022 Sep; 23(8):895-910. PubMed ID: 35233903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women.
    Summers NA; Lahiri CD; Angert CD; Aldredge A; Mehta CC; Ofotokun I; Kerchberger AM; Gustafson D; Weiser SD; Kassaye S; Konkle-Parker D; Sharma A; Adimora AA; Bolivar H; Cocohoba J; French AL; Golub ET; Sheth AN
    J Acquir Immune Defic Syndr; 2020 Nov; 85(3):355-362. PubMed ID: 33060420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants.
    Verboeket SO; Boyd A; Wit FW; Verheij E; Schim van der Loeff MF; Kootstra N; van der Valk M; Reiss P;
    PLoS One; 2021; 16(5):e0251205. PubMed ID: 33951089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Hyperlipidemia among Adults Initiating Antiretroviral Therapy in the HIV Outpatient Study (HOPS), USA, 2007-2021.
    Li J; Agbobli-Nuwoaty S; Palella FJ; Novak RM; Tedaldi E; Mayer C; Mahnken JD; Hou Q; Carlson K; Thompson-Paul AM; Durham MD; Buchacz K
    AIDS Res Treat; 2023; 2023():4423132. PubMed ID: 38078054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between weight gain and insulin resistance in people living with HIV switching to integrase strand transfer inhibitors-based regimens.
    Milic J; Renzetti S; Ferrari D; Barbieri S; Menozzi M; Carli F; Dolci G; Ciusa G; Mussini C; Calza S; Guaraldi G
    AIDS; 2022 Oct; 36(12):1643-1653. PubMed ID: 35727163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study.
    Serrano-Villar S; Martínez-Sanz J; Ron R; Talavera-Rodríguez A; Fernández-Felix BM; Herrera S; Muriel A; Fanjul F; Portilla J; Muñoz J; Amador C; de Zárraga MA; Vivancos MJ; Moreno S;
    Lancet HIV; 2020 Aug; 7(8):e565-e573. PubMed ID: 32763219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INSTI-Based Initial Antiretroviral Therapy in Adults with HIV, the HIV Outpatient Study, 2007-2018.
    Mayer S; Rayeed N; Novak RM; Li J; Palella FJ; Buchacz K;
    AIDS Res Hum Retroviruses; 2021 Oct; 37(10):768-775. PubMed ID: 34030459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No overall impact on rate of weight gain with integrase inhibitor-containing regimens in antiretroviral-naïve adults.
    Burns JE; Stirrup O; Waters L; Dunn D; Gilson R; Pett SL
    HIV Med; 2022 Mar; 23(3):294-300. PubMed ID: 34634168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergent drug resistance with integrase strand transfer inhibitor-based regimens.
    Lepik KJ; Harrigan PR; Yip B; Wang L; Robbins MA; Zhang WW; Toy J; Akagi L; Lima VD; Guillemi S; Montaner JSG; Barrios R
    AIDS; 2017 Jun; 31(10):1425-1434. PubMed ID: 28375875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.